scPharmaceuticals Inc.
SCPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $36,332 | $13,593 | $0 | $0 |
| % Growth | 167.3% | – | – | – |
| Cost of Goods Sold | $11,361 | $3,811 | $468 | $438 |
| Gross Profit | $24,971 | $9,782 | -$468 | -$438 |
| % Margin | 68.7% | 72% | – | – |
| R&D Expenses | $12,098 | $11,809 | $15,533 | $16,039 |
| G&A Expenses | $0 | $53,369 | $20,624 | $9,784 |
| SG&A Expenses | $77,649 | $53,369 | $20,624 | $9,784 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $89,747 | $65,178 | $36,157 | $25,823 |
| Operating Income | -$64,776 | -$55,396 | -$36,157 | -$25,823 |
| % Margin | -178.3% | -407.5% | – | – |
| Other Income/Exp. Net | -$20,372 | $586 | -$681 | -$2,211 |
| Pre-Tax Income | -$85,148 | -$54,810 | -$36,838 | -$28,034 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$85,148 | -$54,810 | -$36,838 | -$28,034 |
| % Margin | -234.4% | -403.2% | – | – |
| EPS | -1.91 | -1.42 | -1.3 | -1.02 |
| % Growth | -34.5% | -9.2% | -27.5% | – |
| EPS Diluted | -1.91 | -1.42 | -1.3 | -1.02 |
| Weighted Avg Shares Out | 44,520 | 38,514 | 28,359 | 27,352 |
| Weighted Avg Shares Out Dil | 44,520 | 38,514 | 28,359 | 27,352 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,444 | $5,104 | $1,203 | $49 |
| Interest Expense | $7,570 | $8,123 | $3,302 | $2,575 |
| Depreciation & Amortization | $148 | $626 | $468 | $438 |
| EBITDA | -$77,430 | -$46,061 | -$33,068 | -$25,021 |
| % Margin | -213.1% | -338.9% | – | – |